AbbVie’s Skyrizifor received EC approval to treat adults with active psoriatic arthritis
AbbVie announced that the European Commission (EC) has approved Skyrizi (risankizumab, 150 mg, subcutaneous injection at week 0, week 4 and every... Read More
Insight on licensing deal of Pfizer and The Medicines Patent Pool for COVID-19 Oral Antiviral Treatment Candidate to Expand market Access in Low- and Middle-Income Countries
Posted on18 Nov 2021
Comments0
Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to life-saving medicines for low-... Read More